Literature DB >> 11915019

Nonalcoholic fatty liver disease: an agenda for clinical research.

Zobair M Younossi1, Anna Mae Diehl, Janus P Ong.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11915019     DOI： 10.1053/jhep.2002.32483

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  45 in total

1.  High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.

Authors:  Stefan B Puchner; Michael T Lu; Thomas Mayrhofer; Ting Liu; Amit Pursnani; Brian B Ghoshhajra; Quynh A Truong; Stephen D Wiviott; Jerome L Fleg; Udo Hoffmann; Maros Ferencik
Journal:  Radiology       Date:  2014-11-04       Impact factor: 11.105

2.  A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.

Authors:  Zobair M Younossi; Sandra Page; Nila Rafiq; Aybike Birerdinc; Maria Stepanova; Noreen Hossain; Arian Afendy; Zahra Younoszai; Zachary Goodman; Ancha Baranova
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

3.  Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.

Authors:  Maria Stepanova; Noreen Hossain; Arian Afendy; Kellie Perry; Zachary D Goodman; Ancha Baranova; Zobair Younossi
Journal:  Obes Surg       Date:  2010-01-30       Impact factor: 4.129

4.  Selection of reference genes for qRT-PCR in high fat diet-induced hepatic steatosis mice model.

Authors:  Lingyan Xu; Xinran Ma; Bin Cui; Xiaoying Li; Guang Ning; Shu Wang
Journal:  Mol Biotechnol       Date:  2011-07       Impact factor: 2.695

5.  Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease.

Authors:  Thomas R Riley; Amin Kahn
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

6.  Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.

Authors:  Harminder Singh; Richard Pollock; Julia Uhanova; Meir Kryger; Kim Hawkins; Gerald Y Minuk
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

7.  Nonalcoholic fatty liver disease treated by gastroplasty.

Authors:  K Jaskiewicz; S Raczynska; R Rzepko; Z Sledziński
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

8.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

Review 9.  Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.

Authors:  Shivakumar Chitturi; Jacob George
Journal:  Curr Gastroenterol Rep       Date:  2003-02

10.  Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease.

Authors:  Ancha Baranova; Karen Schlauch; Hazem Elariny; Mohammed Jarrar; Chase Bennett; Clare Nugent; Shobha J Gowder; Zahra Younoszai; Rochelle Collantes; Vikas Chandhoke; Zobair M Younossi
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.